FDA finance crisis hits drug approval times
The US healthcare regulator has admitted for the first time that a crisis in its finances has led to a slowdown in approval times for new drugs. The world's largest pharmaceutical companies have
The US healthcare regulator has admitted for the first time that a crisis in its finances has led to a slowdown in approval times for new drugs. The world's largest pharmaceutical companies have